RUDOLPH WILLIS: Open Payments
NPI 1104887819 · IRVINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 16 payments from 7 companies in 2025. Trend: 2023 $1,236 · 2024 $654 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Novo Nordisk Inc | 5 | $98 |
| Indivior Inc. | 2 | $52 |
| Orexo US, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| Amgen Inc. | 2 | $31 |
Products named: AIRSUPRA, Ozempic, SUBLOCADE, Zubsolv, JARDIANCE, MOUNJARO, REPATHA.
Industry payments across NJ — which companies pay providers there.
